ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Durham, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Durham, NC, USA:

REAL-Fam Feasibility Study for Youth Diabetes Management

how a rural family participates in and manages their child's type 1 diabetes, their family quality of life, and the child's health outcomes....

Enrolling
Type 1 Diabetes
Behavioral: REAL-Fam Occupational Therapy Family Coaching
University of North Carolina (UNC)
University of North Carolina (UNC)

Chapel Hill, North Carolina, United States

The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: TOL-3021 Placebo
Biological: TOL-3021

Phase 2

Tolerion

Chapel Hill, North Carolina, United States and 22 other locations

blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Lispro
Drug: HDV-Lispro

Phase 2

Diasome Pharmaceuticals

Chapel Hill, North Carolina, United States and 27 other locations

The purpose of this study is to assess the safety, tolerability and effectiveness of RF vapor ablation of the proximal intestinal mucosa. This study...

Enrolling
Type-2 Diabetes Mellitus
Device: RF Vapor Ablation
Aqua Medical

Chapel Hill, North Carolina, United States and 3 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Wake Forest, North Carolina, United States of America and 24 other locations

This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good...

Enrolling
Type II Diabetes Mellitus
Other: Placebo
Drug: CX11

Phase 2

Corxel Pharmaceuticals

Raleigh, North Carolina, United States and 45 other locations

Locations recently updated

The primary objective of this study is to demonstrate that KAI-9531 subcutaneous (SC) injection once weekly is superior to placebo on:* Percent chang...

Enrolling
Overweight With Diabetes
Obesity With Diabetes
Drug: KAI-9531
Drug: Placebo

Phase 3

Kailera

Greensboro, North Carolina, United States and 43 other locations

The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT/ rilparencel)
Procedure: Sham Comparator

Phase 3

Prokidney

Chapel Hill, North Carolina, United States and 96 other locations

implementation study to improve guideline-recommended screening and treatment of chronic kidney disease (CKD) in individuals with type 2 diabetes...

Enrolling
Type 2 Diabetes Mellitus (T2DM)
Type 2 DM
Other: (IRIS-CKD Management Program): Education
Other: (IRIS-CKD Management Program): GDMT
Duke University
Duke University

Durham, North Carolina, United States and 5 other locations

IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes...

Enrolling
Type 2 Diabetes Mellitus (T2DM)
Type 2 DM
Other: (IRIS-CKD Screening Program): Home Kit
Other: (IRIS-CKD Screening Program): Standard Lab Order
Duke University
Duke University

Durham, North Carolina, United States and 5 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems